| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2380270A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2379863A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379777A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | CA2379237A1 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | CA2378403A1 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | CA2375650A1 Ehrlichia canis genes and vaccines |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 02/01/2001 | CA2343714A1 Homeobox gene encoding a protein involved in differentiation |
| 01/31/2001 | EP1072611A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 01/31/2001 | EP1072610A1 Novel cytokine-like protein |
| 01/31/2001 | EP1072010A2 Oligonucleotide mediated nucleic acid recombination |
| 01/31/2001 | EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway |
| 01/31/2001 | EP1071957A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/31/2001 | EP1071955A1 Improved immunodiagnostic assays using reducing agents |
| 01/31/2001 | EP1071798A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 01/31/2001 | EP1071792A2 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
| 01/31/2001 | EP1071787A1 Tao protein kinases and methods of use |
| 01/31/2001 | EP1071783A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 01/31/2001 | EP1071780A1 Soluble protein ztmpo-1 |
| 01/31/2001 | EP1071779A1 Vertebrate patched-2 protein |
| 01/31/2001 | EP1071777A2 Human nucleic acid sequences of normal uterus tissue |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071775A2 Human nucleic acid sequences of endometrium tumour tissue |
| 01/31/2001 | EP1071773A1 Sh2 domain-containing peptides |
| 01/31/2001 | EP1071771A2 Gene encoding syntaxin interacting protein |
| 01/31/2001 | EP1071770A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/31/2001 | EP1071769A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence |
| 01/31/2001 | EP1071767A1 Gene coding for heliomicine and use thereof |
| 01/31/2001 | EP1071766A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb |
| 01/31/2001 | EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 01/31/2001 | EP1071754A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use |
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071718A1 Matrix binding factor |
| 01/31/2001 | EP1071715A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA) |
| 01/31/2001 | EP1071714A1 A novel g-protein coupled receptor |
| 01/31/2001 | EP1071707A1 Novel omega conotoxin peptides |
| 01/31/2001 | EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use |
| 01/31/2001 | EP1071705A2 Peptides causing formation of compact structures |
| 01/31/2001 | EP1071700A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/31/2001 | EP1071697A1 Regulated target expression for screening |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071458A1 Humanized antibody and uses thereof |
| 01/31/2001 | EP1071444A1 A method of detecting drug-receptor and protein-protein interactions |
| 01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 01/31/2001 | EP1071327A1 Autoantigenic fragments, methods and assays |
| 01/31/2001 | EP0920528A4 Synthetic protein folding catalysis |
| 01/31/2001 | EP0724639B1 Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/31/2001 | CN1282369A Polypeptides having aminopepyidase activity and nucleic acids encoding same |
| 01/31/2001 | CN1282338A A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 01/31/2001 | CN1282255A IFNAR2/I FN complex |
| 01/31/2001 | CN1061374C Synthetic DNA series of coded sweet protein and production method thereof |
| 01/31/2001 | CN1061373C Method for preparing monomer insulin |
| 01/30/2001 | US6180776 MTS2 gene |
| 01/30/2001 | US6180775 Bacillus thuringiensis isolates active against weevils |
| 01/30/2001 | US6180773 The cc type chemokines belong to a family of polypeptides which have proven to be mediators of immune reactions, and which have antiviral activity with respect to hiv |
| 01/30/2001 | US6180771 Given nucleotide sequence; useful for pharmaceutical administration or methods of diagnosing sensitivity to house dust mites |
| 01/30/2001 | US6180760 Of given amino acid sequence, a cdna sequence, and antibody specifically recognizing 1-afadin; 1-afadin contributes to the cell-to-cell adherens junction (aj) having a role in individual formation of animals and pathigenesis |
| 01/30/2001 | US6180752 Polyasparaginic acid homopolymers an copolymers, biotechnical production and use thereof |
| 01/30/2001 | US6180614 Methods of immunization of aquaculture species by introducing dna expression systems into the aquaculture species |
| 01/30/2001 | US6180401 Polypeptide production in animal cell culture |
| 01/30/2001 | US6180392 Streptomyces strains and process to produce single streptogramin component |
| 01/30/2001 | US6180391 Vector for cloning preferential heterologous nucleotide sequences |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180386 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme |
| 01/30/2001 | US6180385 Nucleotide sequences coding a viral enzymatic polypeptide; for the detection of modulators of proteolytic activity |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180377 Humanized antibodies |
| 01/30/2001 | US6180371 Modified factor VIII |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180369 Varicella-zoster virus antigen |
| 01/30/2001 | US6180367 Recovering heterologous proteins from microorganisms; culture transformed microorganismal cells with expression vector, incubate with inducer, propagate, lyse cells and recover accumulated heterologous protein |
| 01/30/2001 | US6180366 Methods for producing heterologous polypeptides in trichothecene-deficient |
| 01/30/2001 | US6180365 Expression vector coding membrane binding polypeptide; for use in diagnosis and treatment of bacterial, fungal or viral infection |
| 01/30/2001 | US6180362 Peptides which inhibit ras protein activity, their preparation and use |
| 01/30/2001 | US6180357 Preparation of preferential anticarcinogenic immunoglobulins; isolating tumor tissue, generating immunoglobulins, test immunoglobulins for preferential toxicity to tumor |
| 01/30/2001 | US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems |
| 01/30/2001 | US6180110 Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| 01/30/2001 | US6180109 Nucleotide and polypeptide sequences of pestivirus strains |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | US6180102 Monoclonal antibody to human Mx protein MxA |
| 01/30/2001 | CA2064558C Method for inhibiting growth of stem cells |
| 01/30/2001 | CA2056997C A human cytokine, interleukin-9 |
| 01/30/2001 | CA2022610C Human gp130 protein |
| 01/25/2001 | WO2001006233A1 Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005997A2 Method for production of tetanus toxin using media substantially free of animal products |
| 01/25/2001 | WO2001005995A1 Method of preparing cell cultivation supernatant |
| 01/25/2001 | WO2001005991A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 01/25/2001 | WO2001005990A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 01/25/2001 | WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | WO2001005978A1 FimH ADHESIN-BASED VACCINES |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |